179 related articles for article (PubMed ID: 19265040)
1. Cardiac-specific deletion of mkk4 reveals its role in pathological hypertrophic remodeling but not in physiological cardiac growth.
Liu W; Zi M; Jin J; Prehar S; Oceandy D; Kimura TE; Lei M; Neyses L; Weston AH; Cartwright EJ; Wang X
Circ Res; 2009 Apr; 104(7):905-14. PubMed ID: 19265040
[TBL] [Abstract][Full Text] [Related]
2. Cdc42 is an antihypertrophic molecular switch in the mouse heart.
Maillet M; Lynch JM; Sanna B; York AJ; Zheng Y; Molkentin JD
J Clin Invest; 2009 Oct; 119(10):3079-88. PubMed ID: 19741299
[TBL] [Abstract][Full Text] [Related]
3. Mixed lineage kinase-3 prevents cardiac dysfunction and structural remodeling with pressure overload.
Calamaras TD; Baumgartner RA; Aronovitz MJ; McLaughlin AL; Tam K; Richards DA; Cooper CW; Li N; Baur WE; Qiao X; Wang GR; Davis RJ; Kapur NK; Karas RH; Blanton RM
Am J Physiol Heart Circ Physiol; 2019 Jan; 316(1):H145-H159. PubMed ID: 30362822
[TBL] [Abstract][Full Text] [Related]
4. Interaction between NFκB and NFAT coordinates cardiac hypertrophy and pathological remodeling.
Liu Q; Chen Y; Auger-Messier M; Molkentin JD
Circ Res; 2012 Apr; 110(8):1077-86. PubMed ID: 22403241
[TBL] [Abstract][Full Text] [Related]
5. Targeted deletion of the extracellular signal-regulated protein kinase 5 attenuates hypertrophic response and promotes pressure overload-induced apoptosis in the heart.
Kimura TE; Jin J; Zi M; Prehar S; Liu W; Oceandy D; Abe J; Neyses L; Weston AH; Cartwright EJ; Wang X
Circ Res; 2010 Mar; 106(5):961-70. PubMed ID: 20075332
[TBL] [Abstract][Full Text] [Related]
6. Src and multiple MAP kinase activation in cardiac hypertrophy and congestive heart failure under chronic pressure-overload: comparison with acute mechanical stretch.
Takeishi Y; Huang Q; Abe J; Glassman M; Che W; Lee JD; Kawakatsu H; Lawrence EG; Hoit BD; Berk BC; Walsh RA
J Mol Cell Cardiol; 2001 Sep; 33(9):1637-48. PubMed ID: 11549343
[TBL] [Abstract][Full Text] [Related]
7. Targeted deletion of ERK2 in cardiomyocytes attenuates hypertrophic response but provokes pathological stress induced cardiac dysfunction.
Ulm S; Liu W; Zi M; Tsui H; Chowdhury SK; Endo S; Satoh Y; Prehar S; Wang R; Cartwright EJ; Wang X
J Mol Cell Cardiol; 2014 Jul; 72(100):104-16. PubMed ID: 24631771
[TBL] [Abstract][Full Text] [Related]
8. Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy.
Wilkins BJ; Dai YS; Bueno OF; Parsons SA; Xu J; Plank DM; Jones F; Kimball TR; Molkentin JD
Circ Res; 2004 Jan; 94(1):110-8. PubMed ID: 14656927
[TBL] [Abstract][Full Text] [Related]
9. MAPK-activated protein kinase-2 in cardiac hypertrophy and cyclooxygenase-2 regulation in heart.
Streicher JM; Ren S; Herschman H; Wang Y
Circ Res; 2010 Apr; 106(8):1434-43. PubMed ID: 20339119
[TBL] [Abstract][Full Text] [Related]
10. Pak1 as a novel therapeutic target for antihypertrophic treatment in the heart.
Liu W; Zi M; Naumann R; Ulm S; Jin J; Taglieri DM; Prehar S; Gui J; Tsui H; Xiao RP; Neyses L; Solaro RJ; Ke Y; Cartwright EJ; Lei M; Wang X
Circulation; 2011 Dec; 124(24):2702-15. PubMed ID: 22082674
[TBL] [Abstract][Full Text] [Related]
11. Mkk4 is a negative regulator of the transforming growth factor beta 1 signaling associated with atrial remodeling and arrhythmogenesis with age.
Davies L; Jin J; Shen W; Tsui H; Shi Y; Wang Y; Zhang Y; Hao G; Wu J; Chen S; Fraser JA; Dong N; Christoffels V; Ravens U; Huang CL; Zhang H; Cartwright EJ; Wang X; Lei M
J Am Heart Assoc; 2014 Apr; 3(2):e000340. PubMed ID: 24721794
[TBL] [Abstract][Full Text] [Related]
12. FoxO1 is required for physiological cardiac hypertrophy induced by exercise but not by constitutively active PI3K.
Weeks KL; Tham YK; Yildiz SG; Alexander Y; Donner DG; Kiriazis H; Harmawan CA; Hsu A; Bernardo BC; Matsumoto A; DePinho RA; Abel ED; Woodcock EA; McMullen JR
Am J Physiol Heart Circ Physiol; 2021 Apr; 320(4):H1470-H1485. PubMed ID: 33577435
[TBL] [Abstract][Full Text] [Related]
13. Phosphoinositide 3-kinase gamma-deficient mice are protected from isoproterenol-induced heart failure.
Oudit GY; Crackower MA; Eriksson U; Sarao R; Kozieradzki I; Sasaki T; Irie-Sasaki J; Gidrewicz D; Rybin VO; Wada T; Steinberg SF; Backx PH; Penninger JM
Circulation; 2003 Oct; 108(17):2147-52. PubMed ID: 12963636
[TBL] [Abstract][Full Text] [Related]
14. GRK5-mediated exacerbation of pathological cardiac hypertrophy involves facilitation of nuclear NFAT activity.
Hullmann JE; Grisanti LA; Makarewich CA; Gao E; Gold JI; Chuprun JK; Tilley DG; Houser SR; Koch WJ
Circ Res; 2014 Dec; 115(12):976-85. PubMed ID: 25332207
[TBL] [Abstract][Full Text] [Related]
15. Small heat-shock protein Hsp20 attenuates beta-agonist-mediated cardiac remodeling through apoptosis signal-regulating kinase 1.
Fan GC; Yuan Q; Song G; Wang Y; Chen G; Qian J; Zhou X; Lee YJ; Ashraf M; Kranias EG
Circ Res; 2006 Nov; 99(11):1233-42. PubMed ID: 17068291
[TBL] [Abstract][Full Text] [Related]
16. Cardiac anti-remodelling effect of aerobic training is associated with a reduction in the calcineurin/NFAT signalling pathway in heart failure mice.
Oliveira RS; Ferreira JC; Gomes ER; Paixão NA; Rolim NP; Medeiros A; Guatimosim S; Brum PC
J Physiol; 2009 Aug; 587(Pt 15):3899-910. PubMed ID: 19505981
[TBL] [Abstract][Full Text] [Related]
17. Deubiquitinating enzyme CYLD mediates pressure overload-induced cardiac maladaptive remodeling and dysfunction via downregulating Nrf2.
Wang H; Lai Y; Mathis BJ; Wang W; Li S; Qu C; Li B; Shao L; Song H; Janicki JS; Sun SC; Wang XL; Tang D; Cui T
J Mol Cell Cardiol; 2015 Jul; 84():143-53. PubMed ID: 25935309
[TBL] [Abstract][Full Text] [Related]
18. Distinct signaling properties of mitogen-activated protein kinase kinases 4 (MKK4) and 7 (MKK7) in embryonic stem cell (ESC) differentiation.
Wang J; Chen L; Ko CI; Zhang L; Puga A; Xia Y
J Biol Chem; 2012 Jan; 287(4):2787-97. PubMed ID: 22130668
[TBL] [Abstract][Full Text] [Related]
19. The scaffold protein muscle A-kinase anchoring protein β orchestrates cardiac myocyte hypertrophic signaling required for the development of heart failure.
Kritzer MD; Li J; Passariello CL; Gayanilo M; Thakur H; Dayan J; Dodge-Kafka K; Kapiloff MS
Circ Heart Fail; 2014 Jul; 7(4):663-72. PubMed ID: 24812305
[TBL] [Abstract][Full Text] [Related]
20. Cardiac overexpression of a G(q) inhibitor blocks induction of extracellular signal-regulated kinase and c-Jun NH(2)-terminal kinase activity in in vivo pressure overload.
Esposito G; Prasad SV; Rapacciuolo A; Mao L; Koch WJ; Rockman HA
Circulation; 2001 Mar; 103(10):1453-8. PubMed ID: 11245652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]